Joincare Pharmaceutical Group Industry Co Ltd Total Liabilities
Joincare Pharmaceutical Group Industry Co Ltd total liabilities. Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) has total liabilities worth CN¥10.96 Billion CNY (≈ $1.60 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Joincare Pharmaceutical Group Industry C liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Joincare Pharmaceutical Group Industry Co Ltd (1997–2025)
Total liabilities of Joincare Pharmaceutical Group Industry Co Ltd from 1997 to 2025. This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Joincare Pharmaceutical Group Industry C (600380) long-term investment share to see how much of total assets are deployed in long-term investments.
Joincare Pharmaceutical Group Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Joincare Pharmaceutical Group Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MultiChoice Group Ltd
JSE:MCG
|
South Africa | ZAC37.64 Billion |
|
China Southern Power Grid Energy Efficiency & Clean Energy Co Ltd
SHE:003035
|
China | CN¥15.37 Billion |
|
Heartflow, Inc. Common Stock
NASDAQ:HTFL
|
USA | $109.83 Million |
|
Ardagh Metal Packaging SA
NYSE:AMBP
|
USA | $5.79 Billion |
|
Worthington Industries Inc
NYSE:WOR
|
USA | $821.02 Million |
|
BBVA Banco Frances SA ADR
F:BFP
|
Germany | €21.69 Trillion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr18.33 Billion |
|
InnoDisk
TWO:5289
|
Taiwan | NT$9.94 Billion |
Liability Composition Analysis (1997–2025)
This chart breaks down Joincare Pharmaceutical Group Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Joincare Pharmaceutical Group Industry C.
Liquidity & Leverage Metrics
Joincare Pharmaceutical Group Industry Co Ltd Total Liabilities Ratios Explained
Joincare Pharmaceutical Group Industry Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Joincare Pharmaceutical Group Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Joincare Pharmaceutical Group Industry Co Ltd (1997–2025)
The table below shows the annual total liabilities of Joincare Pharmaceutical Group Industry Co Ltd from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥11.05 Billion ≈ $1.62 Billion |
-10.33% |
| 2024-12-31 | CN¥12.32 Billion ≈ $1.80 Billion |
-10.21% |
| 2023-12-31 | CN¥13.72 Billion ≈ $2.01 Billion |
+0.07% |
| 2022-12-31 | CN¥13.71 Billion ≈ $2.01 Billion |
+25.49% |
| 2021-12-31 | CN¥10.92 Billion ≈ $1.60 Billion |
+22.47% |
| 2020-12-31 | CN¥8.92 Billion ≈ $1.31 Billion |
+10.76% |
| 2019-12-31 | CN¥8.05 Billion ≈ $1.18 Billion |
-7.31% |
| 2018-12-31 | CN¥8.69 Billion ≈ $1.27 Billion |
+1.11% |
| 2017-12-31 | CN¥8.59 Billion ≈ $1.26 Billion |
+27.56% |
| 2016-12-31 | CN¥6.74 Billion ≈ $985.83 Million |
+3.83% |
| 2015-12-31 | CN¥6.49 Billion ≈ $949.47 Million |
+17.06% |
| 2014-12-31 | CN¥5.54 Billion ≈ $811.09 Million |
+17.41% |
| 2013-12-31 | CN¥4.72 Billion ≈ $690.83 Million |
+13.39% |
| 2012-12-31 | CN¥4.16 Billion ≈ $609.24 Million |
+24.11% |
| 2011-12-31 | CN¥3.35 Billion ≈ $490.87 Million |
+87.33% |
| 2010-12-31 | CN¥1.79 Billion ≈ $262.03 Million |
+2.67% |
| 2009-12-31 | CN¥1.74 Billion ≈ $255.23 Million |
-10.99% |
| 2008-12-31 | CN¥1.96 Billion ≈ $286.75 Million |
+0.81% |
| 2007-12-31 | CN¥1.94 Billion ≈ $284.46 Million |
+4.31% |
| 2006-12-31 | CN¥1.86 Billion ≈ $272.71 Million |
+36.66% |
| 2005-12-31 | CN¥1.36 Billion ≈ $199.56 Million |
-5.37% |
| 2004-12-31 | CN¥1.44 Billion ≈ $210.88 Million |
+4.17% |
| 2003-12-31 | CN¥1.38 Billion ≈ $202.44 Million |
+170.51% |
| 2002-12-31 | CN¥511.40 Million ≈ $74.83 Million |
+47.72% |
| 2001-12-31 | CN¥346.20 Million ≈ $50.66 Million |
-31.01% |
| 2000-12-31 | CN¥501.77 Million ≈ $73.43 Million |
+1.96% |
| 1999-12-31 | CN¥492.14 Million ≈ $72.02 Million |
+8.74% |
| 1998-12-31 | CN¥452.60 Million ≈ $66.23 Million |
+33.54% |
| 1997-12-31 | CN¥338.94 Million ≈ $49.60 Million |
-- |
About Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and tradi… Read more